4//SEC Filing
Nark Ted C 4
Accession 0001628280-25-053188
CIK 0001723128other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:21 PM ET
Size
4.9 KB
Accession
0001628280-25-053188
Insider Transaction Report
Form 4
Nark Ted C
Director
Transactions
- Sale
Class A Common Stock
2025-11-17$11.72/sh−50,000$586,000→ 291,029 total
Footnotes (1)
- [F1]The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.70 to $11.75 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001316851
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:21 PM ET
- Size
- 4.9 KB